Gijs, M.; Penner, G.; Blackler, G.B.; Impens, N.R.E.N.; Baatout, S.; Luxen, A.; Aerts, A.M.
Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer. Pharmaceuticals 2016, 9, 29.
https://doi.org/10.3390/ph9020029
AMA Style
Gijs M, Penner G, Blackler GB, Impens NREN, Baatout S, Luxen A, Aerts AM.
Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer. Pharmaceuticals. 2016; 9(2):29.
https://doi.org/10.3390/ph9020029
Chicago/Turabian Style
Gijs, Marlies, Gregory Penner, Garth B. Blackler, Nathalie R.E.N. Impens, Sarah Baatout, André Luxen, and An M. Aerts.
2016. "Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer" Pharmaceuticals 9, no. 2: 29.
https://doi.org/10.3390/ph9020029
APA Style
Gijs, M., Penner, G., Blackler, G. B., Impens, N. R. E. N., Baatout, S., Luxen, A., & Aerts, A. M.
(2016). Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer. Pharmaceuticals, 9(2), 29.
https://doi.org/10.3390/ph9020029